Market Introduction
Hemostasis analyzers are devices that measure clotting mechanisms of hemostasis to detect clotting deficiencies and facilitate the treatment of patients with an excess bleeding condition by medical practitioners. Constant technical advancement has led to the launch of many innovative drugs, and instruments such as high-performance hemostasis analyzers are projected to fuel demand growth for hemostasis analyzers.
The report provides trends prevailing in the Europe hemostasis analyzers market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to rising number of cardiovascular diseases and rise in the geriatric population are the key factors driving the market growth. However, the market is expected to experience slow growth during the forecast period owing to high cost of fully automated hemostasis analyzer.
After Asia, the European region is highly affected by the outbreak of the COVID-19 pandemic. Countries like Italy, Spain, the UK, Germany, France, and other European counties such as Russia, Switzerland are highly affected. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries, and the number of deaths is also high. According to the International Health Regulation, the current coronavirus (COVID-19) outbreak has been declared by WHO as a Public Health Emergency of International Concern. The blood clots associated with the COVID19 infection and the specific vaccines are among the critical concern. However, the incidence of blood clotting due to the COVID19 vaccine is rare, and the region's regulatory agencies in the region have confirmed it is closely monitored. Therefore, it is expected that the growth of the market is likely to be slower in the following few years.
Market Overview and Dynamics
The Europe hemostasis analyzers market in the Europe is expected to grow from US$ 1,057.50 million in 2021 to US$ 1,970.20 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028. Automation is emerging as an approach to minimize human involvement in laboratory processes. The automation of routine laboratory procedures with the help of dedicated workstations and system software helps increase efficiency and reduce human errors. Laboratories are increasingly adopting laboratory information management systems (LIMS) and other automation tools to maintain stringent regulatory compliance, increase efficiency and productivity, and enhance data security and integrity. As per the study published in the Journal of Lab Automation, the error frequencies in fully automated, semiautomated, and manual operations are 1–5%, 1–10%, and 10–30%, respectively. Moreover, high volumes of data generated by laboratory systems are triggering the demand for effective data processing, analysis, and sharing methods, thereby highlighting the need for efficient and cost-effective solutions such as the LIMS.
In terms of product type, the laboratory analyzer segment accounted for the largest share of the Europe hemostasis analyzers market in 2020. In terms of test, the d-dimer test segment accounted for the largest share of the Europe hemostasis analyzers market in 2020. In terms of end user, the hospital/clinics segment accounted for the largest share of the Europe hemostasis analyzers market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Europe hemostasis analyzers market in Europe are company websites, annual reports, financial reports, national government documents, and statistical databases, among others. Major companies listed in the report are Siemens Healthineers AG , Abbott , Sysmex Corporation , Nihon Kohden Corporation ,THERMO FISHER SCIENTIFIC INC. ,HOFFMANN-LA ROCHE LTD. , Instrumentation Laboratory Company.
Reasons to buy report
Europe Hemostasis Analyzers Market Segmentation
By Product Type
By Test
By Country
Companies Mentioned -
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,057.50 Million |
| Market Size by 2028 | US$ 1,970.20 Million |
| CAGR (2021 - 2028) | 9.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Hemostasis Analyzers Market is valued at US$ 1,057.50 Million in 2021, it is projected to reach US$ 1,970.20 Million by 2028.
As per our report Europe Hemostasis Analyzers Market, the market size is valued at US$ 1,057.50 Million in 2021, projecting it to reach US$ 1,970.20 Million by 2028. This translates to a CAGR of approximately 9.3% during the forecast period.
The Europe Hemostasis Analyzers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Hemostasis Analyzers Market report:
The Europe Hemostasis Analyzers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Hemostasis Analyzers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Hemostasis Analyzers Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Hemostasis Analyzers Market
